Population Health Sciences Institute, Newcastle University, Newcastle, UK.
Department of Woman-Mother-Child, University Medical Center CHUV, Lausanne, Switzerland.
Birth Defects Res. 2022 Dec 1;114(20):1404-1416. doi: 10.1002/bdr2.2117. Epub 2022 Nov 8.
The total prevalence of congenital heart defects (CHDs) varies by populations and over time. Studies that examine trends in the prevalence of CHD in different regions may shed light on our understanding of the occurrence of CHD and the impact of different risk factors.
To examine trends in total and live birth prevalence of nonsyndromic CHD in Europe between the years 2008 and 2015 and to investigate if the decreasing trend reported by previous studies is continuing.
Cases of CHD delivered between January 1, 2008 and December 31, 2015 notified to 25 population-based EUROCAT (European Surveillance of Congenital Anomalies) registries in 14 countries, formed the population-based case-series. Prevalence (total/live) rates and 95% confidence intervals were calculated as the number of cases per 10,000 births (live and stillbirths). Time trends in prevalence of all nonsyndromic CHDs and for three CHD severity groups (very severe, severe, and less severe) were plotted using a Poisson regression multilevel approach.
The total prevalence of nonsyndromic CHD was 57.1 per 10,000 births (live births and stillbirths) for the 8-year period and remained stable across the three CHD severity groups while the live birth prevalence was 60.2 per 10,000 births. There was considerable variation in the reported total CHD prevalence and the direction of trends by registry. A decreasing prevalence of CHD was observed for the Norway and England/Wales registries, whereas the CHD prevalence increased for registries in Italy and Croatia.
The total prevalence of CHD in Europe between the years 2008 and 2015 remained stable for all CHD and across the three CHD severity groups. The decreasing trend reported by previous studies has not continued. However, we found significant differences in the total and live birth prevalence by registry.
先天性心脏病(CHD)的总患病率因人群和时间而异。研究不同地区 CHD 患病率的趋势可以帮助我们了解 CHD 的发生情况和不同危险因素的影响。
检查 2008 年至 2015 年欧洲非综合征性 CHD 的总患病率和活产儿患病率趋势,并调查之前研究报告的下降趋势是否仍在继续。
使用 25 个基于人群的 EUROCAT(欧洲先天性异常监测)登记处报告的 2008 年 1 月 1 日至 2015 年 12 月 31 日期间分娩的 CHD 病例,形成基于人群的病例系列。患病率(总/活)率和 95%置信区间计算为每 10000 例活产和死产的病例数。使用泊松回归多水平方法绘制所有非综合征性 CHD 及三个 CHD 严重程度组(非常严重、严重和较轻)的患病率时间趋势。
8 年间,非综合征性 CHD 的总患病率为每 10000 例活产和死产 57.1 例,三个 CHD 严重程度组的患病率保持稳定,而活产儿患病率为每 10000 例活产 60.2 例。各登记处报告的总 CHD 患病率和趋势方向存在较大差异。挪威和英格兰/威尔士登记处观察到 CHD 患病率下降,而意大利和克罗地亚登记处的 CHD 患病率则有所上升。
2008 年至 2015 年期间,欧洲所有 CHD 和三个 CHD 严重程度组的 CHD 总患病率保持稳定。之前研究报告的下降趋势并未持续。然而,我们发现各登记处的总患病率和活产儿患病率存在显著差异。